223 related articles for article (PubMed ID: 25881178)
1. Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.
van der Putten IM; Evers SM; Deogaonkar R; Jit M; Hutubessy RC
BMC Public Health; 2015 Apr; 15():356. PubMed ID: 25881178
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.
Deogaonkar R; Hutubessy R; van der Putten I; Evers S; Jit M
BMC Public Health; 2012 Oct; 12():878. PubMed ID: 23072714
[TBL] [Abstract][Full Text] [Related]
3. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
[TBL] [Abstract][Full Text] [Related]
5. Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.
Brinsmead R; Hill S; Walker D
Pediatr Infect Dis J; 2004 Jan; 23(1):32-7. PubMed ID: 14743043
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective.
Annemans L; Beutels P; Bloom DE; De Backer W; Ethgen O; Luyten J; Van Wilder P; Willem L; Simoens S
Value Health; 2021 Jan; 24(1):105-111. PubMed ID: 33431141
[TBL] [Abstract][Full Text] [Related]
7. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of vaccines in Canada: A systematic review.
Chit A; Lee JK; Shim M; Nguyen VH; Grootendorst P; Wu J; Van Exan R; Langley JM
Hum Vaccin Immunother; 2016 May; 12(5):1257-64. PubMed ID: 26890128
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators.
Hopman HA; Crowcroft NS; Cesuroglu T; Langley JM
Vaccine; 2020 Mar; 38(11):2512-2518. PubMed ID: 32057578
[TBL] [Abstract][Full Text] [Related]
10. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
Ozawa S; Clark S; Portnoy A; Grewal S; Stack ML; Sinha A; Mirelman A; Franklin H; Friberg IK; Tam Y; Walker N; Clark A; Ferrari M; Suraratdecha C; Sweet S; Goldie SJ; Garske T; Li M; Hansen PM; Johnson HL; Walker D
Bull World Health Organ; 2017 Sep; 95(9):629-638. PubMed ID: 28867843
[TBL] [Abstract][Full Text] [Related]
11. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
[TBL] [Abstract][Full Text] [Related]
12. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
13. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
[TBL] [Abstract][Full Text] [Related]
14. Evidence-informed vaccine decision making: The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands.
van der Putten IM; Paulus ATG; Hiligsmann M; Hutubessy RCW; Evers SMAA
Health Policy; 2019 Mar; 123(3):260-266. PubMed ID: 30219371
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
[TBL] [Abstract][Full Text] [Related]
16. Global economic evaluations of rotavirus vaccines: A systematic review.
Kotirum S; Vutipongsatorn N; Kongpakwattana K; Hutubessy R; Chaiyakunapruk N
Vaccine; 2017 Jun; 35(26):3364-3386. PubMed ID: 28504193
[TBL] [Abstract][Full Text] [Related]
17. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.
Watson CH; Edmunds WJ
Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C42-54. PubMed ID: 25921288
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?
Pan XF; Griffiths UK; Pennington M; Yu H; Jit M
Vaccine; 2015 Nov; 33(46):6164-72. PubMed ID: 26435189
[TBL] [Abstract][Full Text] [Related]
19. The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness.
Luyten J; Beutels P
Health Aff (Millwood); 2016 Feb; 35(2):212-8. PubMed ID: 26858372
[TBL] [Abstract][Full Text] [Related]
20. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
Knobler S; Bok K; Gellin B
Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
